Biological

Donor Lymphocytes clinical trials

studies test it: 5
open now: 0
in phase 3: 0
first study started: 2001

How each study uses Donor Lymphocytes is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

donor lymphocytes: 4

Studies by the year they started

5 studies that test it; most in 2001 (1)

Studies that test Donor Lymphocytes, by start year
Year	Studies
2001	1
2003	1
2010	1
2013	1
2014	1

By phase

A phase 1/2 study counts in both.

Phase 2: 3
No phase: 2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Leukemia: 2
Precursor Cell Lymphoblastic Leukemia-Lymphoma: 1
Neoplasms: 1
Leukemia, Megakaryoblastic, Acute: 1

Who runs them

Industry 0 · Other 5

Roswell Park Cancer Institute (1) · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1) · Sidney Kimmel Cancer Center at Thomas Jefferson University (1) · Rutgers, The State University of New Jersey (1) · Alliance for Clinical Trials in Oncology (1)

Often tested with

Tested in the same studies.

Fludarabine phosphate (3) · Fludarabine (3) · Mycophenolic Acid (3) · Tacrolimus (2) · Cyclosporine (1) · Cyclophosphamide (1) · Cytarabine (1) · Granulocyte Colony-Stimulating Factor (1)

Studies

Open first, then newest update. How each study uses Donor Lymphocytes is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Given beside what is tested · 4 — Donor Lymphocytes is usual care or a partner of the new treatment